Beyond Air Registers Resale of 5.4M Shares from $10.2M Private Placement
XAIR is trading near its 52-week low of $5.02 (14% above the low).
Summary
Beyond Air filed an S-3 to register the resale of 5.4 million shares from its July private placement, including shares underlying warrants. The filing reveals the selling stockholders and warrant terms, and makes the shares tradable, creating potential overhang.
Key Events · Financing and Capital Events · XAIR
-
Resale Registration Filed
S-3 registers 5,417,538 shares for resale by selling stockholders, including 167,011 common shares, 1,638,835 pre-funded warrant shares, and 3,611,692 common warrant shares.
-
Selling Stockholders Identified
Atlas Private Holdings and Armistice Capital Master Fund each hold 2,650,176 shares; CEO Robert Goodman holds 104,166 shares and CFO Daniel Moorhead holds 13,020 shares.
-
Warrant Terms Disclosed
Pre-funded warrants have a $0.0001 exercise price; Series A and Series B warrants have a $5.51 exercise price. Series A warrants expire on the earlier of one year or 45 days after FDA approval of LungFit PH II PMA supplement.
-
Lock-Up Restrictions
Company cannot issue common stock or equivalents for 60 days after registration effectiveness, and cannot enter Variable Rate Transactions for 180 days, with an exception for an ATM with Cantor Fitzgerald after 60 days.
Analysis · XAIR · Industrial Applications And Services
This S-3 registers the resale of 5,417,538 shares issued in the July 31 private placement, including shares underlying pre-funded and common warrants. The registration makes these shares freely tradable, creating potential selling pressure. The filing also reveals new details: the two institutional investors (Atlas and Armistice) each hold 2.65M shares, and the Series A warrants expire on the earlier of one year or 45 days after FDA approval of LungFit PH II, which could accelerate dilution if the PMA supplement is approved. The company is in a precarious position with a going concern warning and only $9.8M in cash, so this registration is a necessary step to provide liquidity to investors but also signals potential overhang.
At the time of this filing, XAIR was trading at $5.71 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.5M. The 52-week trading range was $5.02 to $95.60. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.